MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Saved in:
| Title: | MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. |
|---|---|
| Authors: | Mitchell JM; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu., Bogenschutz M; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA., Lilienstein A; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA., Harrison C; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., Kleiman S; Kleiman Consulting and Psychological Services, Sayreville, NJ, USA., Parker-Guilbert K; KPG Psychological Services LLC, Brunswick, ME, USA., Ot'alora G M; Aguazul-Bluewater Inc., Boulder, CO, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA., Garas W; Aguazul-Bluewater Inc., Boulder, CO, USA., Paleos C; Nautilus Sanctuary, New York, NY, USA., Gorman I; Fluence, Woodstock, NY, USA., Nicholas C; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Mithoefer M; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.; Medical University of South Carolina, Charleston, SC, USA., Carlin S; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA., Poulter B; Aguazul-Bluewater Inc., Boulder, CO, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA., Mithoefer A; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA., Quevedo S; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.; San Francisco Insight and Integration Center, San Francisco, CA, USA., Wells G; San Francisco Insight and Integration Center, San Francisco, CA, USA., Klaire SS; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada., van der Kolk B; Boston University School of Medicine, Boston, MA, USA., Tzarfaty K; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA., Amiaz R; Chaim Sheba Medical Center, Tel HaShomer, Israel., Worthy R; Ray Worthy Psychiatry LLC, New Orleans, LA, USA., Shannon S; Wholeness Center, Fort Collins, CO, USA., Woolley JD; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA., Marta C; New School Research LLC, North Hollywood, CA, USA., Gelfand Y; Zen Therapeutic Solutions, Mt Pleasant, SC, USA., Hapke E; University of Toronto, Toronto, Ontario, Canada., Amar S; Dr Simon Amar Inc., Montreal, Quebec, Canada., Wallach Y; Be'er Ya'akov Ness Ziona Mental Health Center, Be'er Ya'akov, Israel., Brown R; Fluence, Woodstock, NY, USA., Hamilton S; Stanford School of Medicine, Stanford, CA, USA., Wang JB; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., Coker A; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., Matthews R; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., de Boer A; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA., Emerson A; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA. |
| Source: | Nature medicine [Nat Med] 2021 Jun; Vol. 27 (6), pp. 1025-1033. Date of Electronic Publication: 2021 May 10. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33972795 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mitchell+JM%22">Mitchell JM</searchLink>; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Bogenschutz+M%22">Bogenschutz M</searchLink>; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lilienstein+A%22">Lilienstein A</searchLink>; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+C%22">Harrison C</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kleiman+S%22">Kleiman S</searchLink>; Kleiman Consulting and Psychological Services, Sayreville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Parker-Guilbert+K%22">Parker-Guilbert K</searchLink>; KPG Psychological Services LLC, Brunswick, ME, USA.<br /><searchLink fieldCode="AU" term="%22Ot'alora+G+M%22">Ot'alora G M</searchLink>; Aguazul-Bluewater Inc., Boulder, CO, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Garas+W%22">Garas W</searchLink>; Aguazul-Bluewater Inc., Boulder, CO, USA.<br /><searchLink fieldCode="AU" term="%22Paleos+C%22">Paleos C</searchLink>; Nautilus Sanctuary, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gorman+I%22">Gorman I</searchLink>; Fluence, Woodstock, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nicholas+C%22">Nicholas C</searchLink>; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Mithoefer+M%22">Mithoefer M</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Carlin+S%22">Carlin S</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Poulter+B%22">Poulter B</searchLink>; Aguazul-Bluewater Inc., Boulder, CO, USA.; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mithoefer+A%22">Mithoefer A</searchLink>; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Quevedo+S%22">Quevedo S</searchLink>; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.; San Francisco Insight and Integration Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wells+G%22">Wells G</searchLink>; San Francisco Insight and Integration Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Klaire+SS%22">Klaire SS</searchLink>; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22van+der+Kolk+B%22">van der Kolk B</searchLink>; Boston University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tzarfaty+K%22">Tzarfaty K</searchLink>; MDMA Therapy Training Program, MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Amiaz+R%22">Amiaz R</searchLink>; Chaim Sheba Medical Center, Tel HaShomer, Israel.<br /><searchLink fieldCode="AU" term="%22Worthy+R%22">Worthy R</searchLink>; Ray Worthy Psychiatry LLC, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Shannon+S%22">Shannon S</searchLink>; Wholeness Center, Fort Collins, CO, USA.<br /><searchLink fieldCode="AU" term="%22Woolley+JD%22">Woolley JD</searchLink>; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marta+C%22">Marta C</searchLink>; New School Research LLC, North Hollywood, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gelfand+Y%22">Gelfand Y</searchLink>; Zen Therapeutic Solutions, Mt Pleasant, SC, USA.<br /><searchLink fieldCode="AU" term="%22Hapke+E%22">Hapke E</searchLink>; University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Amar+S%22">Amar S</searchLink>; Dr Simon Amar Inc., Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Wallach+Y%22">Wallach Y</searchLink>; Be'er Ya'akov Ness Ziona Mental Health Center, Be'er Ya'akov, Israel.<br /><searchLink fieldCode="AU" term="%22Brown+R%22">Brown R</searchLink>; Fluence, Woodstock, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+S%22">Hamilton S</searchLink>; Stanford School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+JB%22">Wang JB</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Coker+A%22">Coker A</searchLink>; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+R%22">Matthews R</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22de+Boer+A%22">de Boer A</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yazar-Klosinski+B%22">Yazar-Klosinski B</searchLink>; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Emerson+A%22">Emerson A</searchLink>; MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Doblin+R%22">Doblin R</searchLink>; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2021 Jun; Vol. 27 (6), pp. 1025-1033. <i>Date of Electronic Publication: </i>2021 May 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33972795 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-021-01336-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1025 Titles: – TitleFull: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mitchell JM – PersonEntity: Name: NameFull: Bogenschutz M – PersonEntity: Name: NameFull: Lilienstein A – PersonEntity: Name: NameFull: Harrison C – PersonEntity: Name: NameFull: Kleiman S – PersonEntity: Name: NameFull: Parker-Guilbert K – PersonEntity: Name: NameFull: Ot'alora G M – PersonEntity: Name: NameFull: Garas W – PersonEntity: Name: NameFull: Paleos C – PersonEntity: Name: NameFull: Gorman I – PersonEntity: Name: NameFull: Nicholas C – PersonEntity: Name: NameFull: Mithoefer M – PersonEntity: Name: NameFull: Carlin S – PersonEntity: Name: NameFull: Poulter B – PersonEntity: Name: NameFull: Mithoefer A – PersonEntity: Name: NameFull: Quevedo S – PersonEntity: Name: NameFull: Wells G – PersonEntity: Name: NameFull: Klaire SS – PersonEntity: Name: NameFull: van der Kolk B – PersonEntity: Name: NameFull: Tzarfaty K – PersonEntity: Name: NameFull: Amiaz R – PersonEntity: Name: NameFull: Worthy R – PersonEntity: Name: NameFull: Shannon S – PersonEntity: Name: NameFull: Woolley JD – PersonEntity: Name: NameFull: Marta C – PersonEntity: Name: NameFull: Gelfand Y – PersonEntity: Name: NameFull: Hapke E – PersonEntity: Name: NameFull: Amar S – PersonEntity: Name: NameFull: Wallach Y – PersonEntity: Name: NameFull: Brown R – PersonEntity: Name: NameFull: Hamilton S – PersonEntity: Name: NameFull: Wang JB – PersonEntity: Name: NameFull: Coker A – PersonEntity: Name: NameFull: Matthews R – PersonEntity: Name: NameFull: de Boer A – PersonEntity: Name: NameFull: Yazar-Klosinski B – PersonEntity: Name: NameFull: Emerson A – PersonEntity: Name: NameFull: Doblin R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2021 Jun Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 27 – Type: issue Value: 6 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |
